Immune Responses against SARS-CoV-2-Questions and Experiences

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• COVID-19 pandemic necessitates understanding SARS-CoV-2 immune responses.
• Immune responses vary widely, from sterilizing immunity to severe disease and long COVID.
• COVID-19 is increasingly viewed as a systemic immune-vascular disease affecting multiple organs.

Purpose of the Study:

• To discuss current knowledge and open questions regarding complex immune responses to SARS-CoV-2.
• To highlight the importance of cellular immunity alongside antibody responses.
• To explore the implications for clinical management and pandemic control.

Main Methods:

• Review of existing literature and preliminary laboratory data.
• Discussion of different types of immune responses (sterilizing, protective, severe disease, long COVID).
• Analysis of the role of neutralizing antibodies versus cellular immunity (T cells).

Main Results:

• Immune responses to SARS-CoV-2 are highly variable, impacting disease severity and transmission.
• Neutralizing antibodies are important, but cellular immunity, particularly T cell responses, may be equally or more critical.
• Current clinical methods for assessing SARS-CoV-2-specific T cell capacity are lacking.
• Vaccination is effective and safer than natural immunity, but concerns about long-term efficacy and side effects persist.

Conclusions:

• A comprehensive understanding of SARS-CoV-2 immunity is essential for improving COVID-19 clinical management.
• Further research is needed to develop reliable methods for assessing cellular immunity.
• Addressing the complexities of immune responses is key to overcoming the pandemic.